Cargando…

CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells

Chromodomain-helicase-DNA-binding protein 4 (CHD4), a core subunit of the nucleosome remodeling and deacetylation (NuRD) complex is highly expressed in several cancers. However, its role in the pathogenesis and progression of papillary thyroid carcinoma (PTC) has not been investigated. We investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pratheeshkumar, Poyil, Siraj, Abdul K., Divya, Sasidharan Padmaja, Parvathareddy, Sandeep Kumar, Alobaisi, Khadija, Al-Sobhi, Saif S., Al-Dayel, Fouad, Al-Kuraya, Khawla S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825451/ https://www.ncbi.nlm.nih.gov/pubmed/33419089 http://dx.doi.org/10.3390/ijms22020504

Ejemplares similares

PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation
por: Siraj, Abdul K., et al.
Publicado: (2021)

Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
por: Siraj, Abdul K., et al.
Publicado: (2020)

Prognostic Value and Function of KLF5 in Papillary Thyroid Cancer
por: Pratheeshkumar, Poyil, et al.
Publicado: (2021)

SUN-132 KLF5 Is a Poor Prognostic Marker and Therapeutic Target for Middle Eastern Papillary Thyroid Carcinoma
por: Al-Kuraya, Khawla S, et al.
Publicado: (2020)

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)

FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2017)

Loss of ZNF677 Expression Is an Independent Predictor for Distant Metastasis in Middle Eastern Papillary Thyroid Carcinoma Patients
por: Siraj, Abdul K., et al.
Publicado: (2021)

Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2020)

Overexpression of the pro‐protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF/MEK signaling
por: Poyil, Pratheesh Kumar, et al.
Publicado: (2023)

Male Sex Is an Independent Predictor of Recurrence-Free Survival in Middle Eastern Papillary Thyroid Carcinoma
por: Siraj, Abdul K., et al.
Publicado: (2022)

Risk Factors for Cervical Lymph Node Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Bilateral multifocality is an independent predictor of patients’ outcome in Middle Eastern papillary thyroid carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2023)

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up
por: Siraj, Abdul K., et al.
Publicado: (2020)

Tumor size is an independent negative prognostic factor for event free survival in children with differentiated thyroid cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Risk Factors for Central Lymph Node Metastases and Benefit of Prophylactic Central Lymph Node Dissection in Middle Eastern Patients With cN0 Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Microscopic Extrathyroidal Extension Results in Increased Rate of Tumor Recurrence and Is an Independent Predictor of Patient’s Outcome in Middle Eastern Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Loss of CDH16 expression is a strong independent predictor for lymph node metastasis in Middle Eastern papillary thyroid cancer
por: Siraj, Abdul K., et al.
Publicado: (2023)

Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2023)

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
por: Masoodi, Tariq, et al.
Publicado: (2020)

POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer
por: Siraj, Abdul K, et al.
Publicado: (2020)

TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

MED12 is recurrently mutated in Middle Eastern colorectal cancer
por: Siraj, Abdul K, et al.
Publicado: (2018)

Loss of ZNF677 expression is a predictive biomarker for lymph node metastasis in Middle Eastern Colorectal Cancer
por: Siraj, Abdul K., et al.
Publicado: (2021)

XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis
por: Hussain, Azhar R., et al.
Publicado: (2017)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

PD-L1 Expression Is an Independent Marker for Lymph Node Metastasis in Middle Eastern Endometrial Cancer
por: Siraj, Abdul K., et al.
Publicado: (2021)

The study of Lynch syndrome in a special population reveals a strong founder effect and an unusual mutational mechanism in familial adenomatous polyposis
por: Siraj, Abdul K, et al.
Publicado: (2020)

MAD-X PTC Integration
por: Schmidt, Frank, et al.
Publicado: (2005)

Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach
por: Bu, Rong, et al.
Publicado: (2022)

High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer
por: Siraj, Abdul K, et al.
Publicado: (2021)

Recurrent Somatic MAP2K1 Mutations in Papillary Thyroid Cancer and Colorectal Cancer
por: Bu, Rong, et al.
Publicado: (2021)

Whole Exome-Wide Association Identifies Rare Variants in GALNT9 Associated with Middle Eastern Papillary Thyroid Carcinoma Risk
por: Bu, Rong, et al.
Publicado: (2023)

Advances in MAD-X using PTC
por: Skowronski, P K, et al.
Publicado: (2007)

PTC_py-ORBIT - Release & Benchmarking
por: HOLMES, Jeffrey A
Publicado: (2014)

APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
por: Siraj, Sarah, et al.
Publicado: (2022)

PD-L1 Expression Is Associated with Deficient Mismatch Repair and Poor Prognosis in Middle Eastern Colorectal Cancers
por: Siraj, Abdul K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5rr1t5c8k0n8k8mgo8gat5q3bd